Trials / Completed
CompletedNCT03051009
Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
A Multi-Centre Trial Investigating the Long Term Safety and Tolerability of Desmopressin (FE 992026) Orally Disintegrating Tablets for the Treatment of Nocturia Due to Nocturnal Polyuria in Japanese Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 503 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Demonstrate the safety and tolerability of desmopressin ODT during long-term treatment of subjects with nocturia due to nocturnal polyuria, for up to 1 year
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desmopressin ODT 25 μg | |
| DRUG | Desmopressin ODT 50 μg |
Timeline
- Start date
- 2017-01-11
- Primary completion
- 2018-09-11
- Completion
- 2018-09-11
- First posted
- 2017-02-13
- Last updated
- 2018-09-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03051009. Inclusion in this directory is not an endorsement.